论文信息 - Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis. - 字舞流文

Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis.

H. Kantarjian | S. Verstovsek | A. Schimmer | W. Walsh | S. Parikh | E. Winton | K. El-Shami | E. Asatiani